Kidney transplantation and ANCA-associated vasculitis

Cleveland Clinic Journal of Medicine

Volumn 69, Issue SUPPL. 2, 2002, Pages

  Van Der Woude, F J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD52 ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; RAPAMYCIN; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANCA ASSOCIATED VASCULITIS; AUSTRALIA; BONE MARROW; CADAVER; CELLULAR IMMUNITY; CONFERENCE PAPER; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; IMMUNOREGULATION; INFECTION COMPLICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; LYMPHOCYTE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN THROMBOSIS; CHRONIC KIDNEY FAILURE; DRUG EFFECT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PATIENT SELECTION; RECURRENT DISEASE; REVIEW; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PATIENT SELECTION; RECURRENCE; VASCULITIS;

EID: 0012119658     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.suppl_2.sii143     Document Type: Conference Paper

References (26)

1. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol 1998; 9:1258-1263.
2. Chabdan SJ. Glomerulonephritis in the renal graft. J Am Soc Nephrol 2001; 12:394-402.
3. Andresdottir MB, Hoitsma AJ, Assmann KJ, Koene RA, Wetzels JF. The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts. Transplantation 1999; 68:623-627.
4. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ. Mycophenolate mofetil for maintenance therapy for Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999; 10:1965-1971.
5. Schnuelle P, Lorenz D, Trede M, van der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998; 9:2135-2141.
6. Wolf G, Porth J, Stahl RAK. Thrombosis associated with cytomegalovirus infection in patients with ANCA-positive vasculitis. Am J Kidney Dis 2001; 38:1-5.
7. Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude FJ. ANCA titres, even of IgG subclasses, and soluble CD 14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2001; 16:1631-1637.
8. Noel L, Morin M, Thervet E, Legendre C, Vandapel O, Kreis H, Lesavre P. Successful kidney transplantation in a patient with microscopic polyarteritis and positive ANCA [abstract]. Clin Exp Immunol 1993; 93 [suppl 1]:43.
9. Grotz W, Wanner C, Rother E, Schollmeyer P. Clinical course of patients with antineutrophil cytoplasm antibodies after kidney transplantation. Nephron 1995; 69:234-236.
10. Frasca G, Neri L, Martello M, Sestigiani E, Borgnino L, Bonomini V. Renal transplantation in patients with microscopic polyarteritis and antimyeloperoxidase antibodies: report of three cases. Nephron 1996; 27:82-85.
11. Nachman PH, Segelmark M, Westman K, Hogan SL, Satterly KK, Charles Jennette J, Falk R. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999; 56:1544-1550.
12. Nowack R, Lehmann H, Flores-Suarez LF, Nanhou A, van der Woude FJ. Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 1999; 34:364-373.
13. Gulati MS, Miller F, Nord EP. Pauci-immune rapidly progressive glomerulonephritis after nephrectomy in a renal donor. Am J Kidney Dis 1999; 33:1-3.
14. Masterson R, Sheerin N, Abbs I, Goldsmith D. Late allograft loss due to recurrence of P-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis. Nephrol Dial Transplant 2001; 16:1705-1707.
15. Nachman PH, Hogan SL, Jennette JC, Falk JR. Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:33-39.
16. Westman KWA, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9:842-852.
17. Schnuelle P, van der Woude FJ. Should A2 kidneys be transplanted into B or O recipients? Lancet 1998; 35:1675-1676.
18. van der Woude FJ, van Es LA, Daha MR. The role of the C-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med 1990; 36:169-171.
19. Peen E, Malone C, Myers C, Williams RC, Peck AB, Csernok E, Gross WL, Staud R. Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Immunol 2001; 125:323-331.
20. Schmitt WE, Heesen C, Csemok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 1992; 35:1088-1092.
21. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CG. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 1993; 91:415-420.
22. Ballieux BE, van der Burg SH, Hagen EC, van der Woude FJ, Melief CJ, Daha MR. Cell-mediated autoimmunity in patients with Wegener's granulomatosis. Clin Exp Immunol 1995; 100:186-193.
23. Christensson M, Petterson E, Sundqvist KG, Christensson B. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy. Clin Nephrol 2000; 54:435-442.
24. Iking-Konert C, Vogt S, Radsak M, Wagner C, Hansch GM, Andrassy K. Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells. Kidney Int 2001; 60:2247-2262.
25. Lockwood CM. Refractory Wegener's granulomatosis: a model for shorter immunotherapy of autoimmune diseases. J R Coll Physicians Lond 1998; 32:473-478.
26. Hagen EC, de Keizer RJ, Andrassy K, van Boven WP, Bruijn JA, van Es LA, van der Woude FJ. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol 1995; 43:351-359.